The term AI in pathology means using artificial intelligence in studying tissues and cells. It includes analyzing large amounts of pathology data with advanced algorithms and machine learning to find, classify, and understand different diseases. AI tools help pathologists by automating repetitive tasks, improving diagnosis accuracy, and speeding up data analysis. This changes the field by increasing efficiency, lowering mistakes, and offering insights for personalized medicine. Examples of AI in pathology are image recognition, predicting disease outcomes, and detecting abnormalities early, which saves time and reduces errors.

The need for AI in pathology is expanding as misdiagnosis cases rise - Misdiagnosis happens when a disease is missed, misclassified, or diagnosed late. This issue in healthcare leads to poor treatment, harm to patients, and higher costs. Prostate cancer, breast cancer, and thyroid cancer are often misdiagnosed. Common causes include general pathologists interpreting scans instead of specialists, physicians not ordering needed follow-up tests, and mistakes in interpreting test results. Artificial intelligence, still developing in clinical use, could assist pathologists by managing workloads and improving diagnostic accuracy.

Challenges: The use of AI in industry is hindered by data privacy issues. Most countries have laws protecting patient health information, and violations can lead to lawsuits and fines. AI tools for patient care need access to various health datasets and must follow data security rules set by governments. This is challenging because many AI platforms are centralized and need significant computing power, which often requires patient data to be stored in a vendor's data center. Ensuring proper security to address data privacy concerns remains a significant challenge in the market.

Creation of AI-powered diagnostic tools - AI-based diagnostic technologies and solutions, ranging from automated cancer detection algorithms to enhanced decision support technology for histopathology analysis, assist pathologists in accurately detecting and classifying diseases.

Patients' disease progression, treatment response, and outcomes can be predicted by evaluating massive amounts of proteomic, genomic, and clinical data using AI algorithms. Thus, AI is widely used in predictive pathology and precision medicine applications, allowing for more tailored treatment techniques.

Koninklijke Philips N.V, F. www Hoffmann-La Roche Ltd, Hologic, Inc, Akoya Biosciences, Inc, Aiosyn, Aiforia Technologies Plc, Indica Labs Inc, OptraScan, Ibex Medical Analytics Ltd, Mindpeak GmbH, Tribun Health, Techcyte, Inc, Deep Bio Inc, Lumea Inc, and Visiopharm are just a few of the major market players that are thoroughly examined in this market study along with revenue analysis, market segments, and competitive landscape data.

By Offering: Based on the Offering, Global AI in Pathology Market is segmented as; End-to-End Solutions, Niche Point Solutions, Technology, Hardware, Microscopes, Scanners, Storage Systems.

By Neural Network: Based on the Neural Network, Global AI in Pathology Market is segmented as; Convolutional Neural Networks, Generative Adversarial Networks, Recurrent Neural Networks, Others Neural Networks.

By Function: Based on the Function, Global AI in Pathology Market is segmented as; Image Analysis, Diagnostics, Workflow Management, Data Management, Predictive Analytics, CDSS, Automated Report Generation, Quality Assurance Tools.

By Use Case: Based on the Use Case, Global AI in Pathology Market is segmented as; Drug Discovery, Disease Diagnosis and Prognosis, Clinical Workflow, Training and Education.

By End User: Based on the End User, Global AI in Pathology Market is segmented as; Pharmaceutical & Biopharmaceutical Companies, Hospitals and Reference Laboratories, Academic & Research Institutes.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.